Vapaliximab

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Vapaliximab
Monoclonal antibody
TypeWhole antibody
SourceChimeric (mouse/human)
TargetVAP-1
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
 ☒N☑Y (what is this?)  (verify)

Vapaliximab is a chimeric monoclonal antibody[1] and an experimental immunosuppressive drug.[citation needed] Development was discontinued by 2012.[2]

References[edit]

  1. ^ WHO Drug Information
  2. ^ "Vapaliximab - AdisInsight". adisinsight.springer.com. Retrieved 2 January 2019.